Literature DB >> 7367458

Effects of heroin and naltrexone on plasma prolactin levels in man.

J Ellingboe, J H Mendelson, J C Kuehnle.   

Abstract

Plasma levels of prolactin were increased following intravenous self-administration of heroin by young men with a history of heroin addiction. Following 10 days of controlled heroin usage, tolerance could be demonstrated to the acute prolactin-releasing effect of heroin. There was no evidence that a single dose of naltrexone affected basal prolactin levels.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7367458     DOI: 10.1016/0091-3057(80)90431-1

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  8 in total

Review 1.  A risk-benefit assessment of naltrexone in the treatment of alcohol dependence.

Authors:  B J Berg; H M Pettinati; J R Volpicelli
Journal:  Drug Saf       Date:  1996-10       Impact factor: 5.606

2.  Neuroadaptations in the striatal proteome of the rat following prolonged excessive sucrose intake.

Authors:  Selina Ahmed; Mohammed Abul Kashem; Ranjana Sarker; Eakhlas U Ahmed; Garth A Hargreaves; Iain S McGregor
Journal:  Neurochem Res       Date:  2014-03-15       Impact factor: 3.996

Review 3.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

4.  Effects of nalbuphine on anterior pituitary and adrenal hormones and subjective responses in male cocaine abusers.

Authors:  Nathalie V Goletiani; Jack H Mendelson; Michelle B Sholar; Arthur J Siegel; Alicja Skupny; Nancy K Mello
Journal:  Pharmacol Biochem Behav       Date:  2007-02-20       Impact factor: 3.533

Review 5.  Naltrexone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the management of opioid dependence.

Authors:  J P Gonzalez; R N Brogden
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

6.  Endogenous opiates modulate the pulsatile secretion of biologically active luteinizing hormone in man.

Authors:  J D Veldhuis; A D Rogol; M L Johnson
Journal:  J Clin Invest       Date:  1983-12       Impact factor: 14.808

7.  Is opium addiction a risk factor for bone loss?

Authors:  M H Gozashti; A Shahesmaeili; N Amini Zadeh
Journal:  Iran Red Crescent Med J       Date:  2011-07-01       Impact factor: 0.611

8.  Hormonal and dietary characteristics in obese human subjects with and without food addiction.

Authors:  Pardis Pedram; Guang Sun
Journal:  Nutrients       Date:  2014-12-31       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.